Estrogen Receptor-negative Breast Cancer Completed Phase 2 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0028543 (Estrogen Receptor-negative Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003199Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerTreatment